Monterona, Alicia N.
HRN: 22-69-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/16/2023
10/23/2023
IV
600mg
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes